Psychopharmacology. Yesterday, today and tomorrow: a point of view.
D000342:Affective Symptoms / Q000517:prevention & control; D000639:Amitriptyline / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D002170:Canada; D002254:Carbonates / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004345:Drug Industry; D004565:Electroconvulsive Therapy; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D001523:Mental Disorders / Q000628:therapy; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D011600:Psychopharmacology / Q000193:education; D012109:Research Support as Topic; D012559:Schizophrenia / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000928:Antidepressive Agents; D002254:Carbonates; D008996:Monoamine Oxidase Inhibitors; D009539:Nicotinic Acids; D014149:Tranquilizing Agents; D014815:Vitamins; D000639:Amitriptyline; D008734:Methoxyhydroxyphenylglycol; D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D008094:Lithium; D007099:Imipramine